Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Disease; Meningococcal Meningitis”

203 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 203 results

Large-scale testing (Phase 3)Study completedNCT02842853
What this trial is testing

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 3,344
Large-scale testing (Phase 3)Study completedNCT00325130
What this trial is testing

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 1,042
Not applicableWithdrawnNCT02727465
What this trial is testing

Host-pathogen Interactions in Meningococcal Disease: Finding the Key That Fits the Lock

Who this might be right for
Meningitis
Public Health England
Testing effectiveness (Phase 2)Study completedNCT01049035
What this trial is testing

A Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 580
Testing effectiveness (Phase 2)Study completedNCT02640404
What this trial is testing

Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 224
Large-scale testing (Phase 3)Study completedNCT03537508
What this trial is testing

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 2,627
Not applicableStudy completedNCT03824093
What this trial is testing

High and Low Resource Interventions to Promote HPV Vaccines

Who this might be right for
Human Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more
Children's Mercy Hospital Kansas City 225
Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Large-scale testing (Phase 3)Study completedNCT02986854
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 704
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Large-scale testing (Phase 3)Study completedNCT03547271
What this trial is testing

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Who this might be right for
Meningococcal Infections
Sanofi Pasteur, a Sanofi Company 1,660
Large-scale testing (Phase 3)Study completedNCT03476135
What this trial is testing

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

Who this might be right for
Meningococcal Infections
Sanofi Pasteur, a Sanofi Company 91
Testing effectiveness (Phase 2)Study completedNCT01272180
What this trial is testing

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

Who this might be right for
Invasive Meningococcal Disease
Novartis Vaccines 484
Post-approval studies (Phase 4)Study completedNCT02526394
What this trial is testing

Pertussis and Meningitis C Concomitant Vaccination in Adolescents

Who this might be right for
PertussisMeningitisPreventive Immunization; Meningitis+1 more
Public Health England 400
Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Not applicableStudy completedNCT00728260
What this trial is testing

36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 1,421
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Testing effectiveness (Phase 2)Study completedNCT00297817
What this trial is testing

Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 203
Testing effectiveness (Phase 2)Study completedNCT00772070
What this trial is testing

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
MeningitisMeningococcemiaNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 173
Post-approval studies (Phase 4)Study completedNCT00581035
What this trial is testing

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 712
Load More Results